HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the journal, please login or register as reader.

2018 Issues

Cover

Vol. 20 • No. N1 • February 2018

In this issue:

  • Treatment Expansion for Opioid Use Disorders in the United States
    Parrino M.
  • Capgras Syndrome in a Heroin Addict. A Case Study
    Lovrecic M., and Lovrecic B.
  • Opioid Maintenance Therapy with Methadone and Levomethadone - Sexual Dysfunction and Treatment Satisfaction
    Schoofs N., Häbel T.H., Bermpohl F., and Gutwinski S.
  • On the Long-Term Status of Treatment-Seeking, Heroin Addicted Patients: A 22-Year Follow-up Study on Mortality and Drug Use in Portugal
    Pombo S., and Félix da Costa N.
  • Methadone Versus Torture: The Perspective of the European Court of Human Rights
    Junod V., Wolff H., Scholten W., Novet B., Greifinger R., Dickson C., and Simon O.
  • Characteristics of Methadone-Related Overdose Deaths and Comparisons between Those Dying on and Off Opioid Agonist Treatment (OAT):  a National Cohort Study.
    Van Hout M.C., Crowley D., Collins C., Barry A., Lyons S., and Delargy I.

 

Cover

Vol. 20 • No. N2 • April 2018

In this issue:

  • Methadone Dose as a Determinant of Infant Outcome During the Peri and Postnatal Period
    Wang M., Stapleton J., and Wolff K.
  • Affective Temperaments in Non-Depressed Patients with Alcohol and Opiate Addictions. Is  the “Dark Side” Associated with Current Depressive Symptoms?
    Kałwa A., Siwy-Hudowska A., and Niznikiewicz M.
  • Heroin Deaths in Norway in 2000 and 2009: A Comparative Study of Polydrug Use
    Karinen R., Konstantinova-Larsen S., Normann P.T., Mørland J., Christophersen A.S., and Arnestad M.
  • Refractory Bipolar Patient Treated with Oral Methadone: Does Methadone Act as Mood Stabilizer?
    Etaee F., Shirdel S., Azarhomayoun A., Nasiri K., and Komaki A.
  • Excess Suicide Mortality in Heroin Use Disorder Patients Seeking Opioid Agonist Treatment in Slovenia and Risk Factors for Suicide
    Lovrecic M., Lovrecic B., Maremmani I., and Maremmani A.G.I.
  • How to Improve a Poorly Running Agonist Opioid Treatment (Aot). Part 5:  Higher Dosage
    Ulmer A., and Meinhold C.

 

Cover

Vol. 20 • No. NS1 • May 2018

In this issue:

Abstract book - 13th European Congress of European Opiate Addiction Treatment Association - EUROPAD - Krakow, Poland, May 25-27, 2018

 

Cover

Vol. 20 • No. N3 • June 2018

In this issue:

  • The Second to Fourth Digit (2d:4d) Ratios in Patients with Heroin Use Disorder
    Canan F., Sogucak S., Karaca S., Tegin C., Gecici O., and Kuloglu M.
  • Novel Psychoactive Synthetic Cannabinoids and Synthetic Cathinones: The Never-Ending Story of Potential Clinical Toxicity
    Lovrecic B., and Lovrecic M.
  • Relationship between Self-Mutilative Behaviour and Novelty Seeking, the Presence of Antisocial and Borderline Personality Disorders, and Severity of Psychopathology in a Sample of Male Patients with Heroin Use Disorder
    Evren C., Karabulut V., Alniak I., Umut G., Cetin T., Evren B., and Agachanli R.
  • Impact of Employment and Marital Status on Lapse Risk Situations among Addicted Patients in Methadone Maintenance Treatment
    Abed M.
  • How to Develop and Implement an Exercise Programme in a Heroin-Assisted Treatment Setting
    Staub L., Gerber M., Vogel M., Dürsteler-Macfarland K., Strom J., Schoen S., Pühse U., and Colledge F.
  • Diversion of Buprenorphine: Scope of the Problem and the Measures Taken to Address It
    Tripathi R., and Sarkar S.

 

Cover

Vol. 20 • No. N4 • August 2018

In this issue:

  • Multidisciplinary Settings in the Treatment of Drug-Addiction: An Experimental Evaluation
    Cicatelli P., Borriello M.T., De Vivo C., D'Oriano V., Fuscone A., Moccia E., and Siconolfi M.
  • A Review of Literature Assessing Public Opinion of Heroin Assisted Treatment
    Berrigan P.
  • Predictors of Retention and Mortality among Patients on Methadone Maintenance Therapy
    Teoh J., Yee A., and Danaee M.
  • Impact of Hepatitis B(Hbv)/C(Hcv) Virus Co-Infection on the Long-Term Survival of Patients with Schizophrenia and Co-Occurring Substance Use Disorders
    Gimelfarb Y., Ligay A., and Ben Tzarfati M.
  • The Cost-Effectiveness of Naloxone Programmes for the Treatment of Heroin Overdoses ‘on the Street': A 2-Year Data Collection by the Street Unit of the Villa Maraini Foundation
    Barra M., Direnzo G.F.M., Patruno F.V., Patti M., Rodoquino G., Rossi E., Santoro R., and Badiani A.
  • Personality Profiles and Aggressive Behaviour of Heroin Use Disorder Patients Compared with Non-Substance-Use Peers
    Conversano C., Belcari I., Marchi L., Maremmani A.G.I., and Maremmani I.

 

Cover

Vol. 20 • No. N5 • October 2018

In this issue:

  • Addiction and self-reported associated sociodemographic factors in a small province of Iran
    Sedaghat Z., Fararouei M., Shahraki G., Karimzadeh Shirazi K., and Haghighi R.E.
  • An evaluation of community pharmacist perception of the misuse and abuse of over-the-counter co-codamol in Cornwell and Devon, UK: a cross-sectional survey
    Barrett R., and Costa D.
  • Switching between lyophilized and sub-lingual buprenorphine formulations in opioid-dependent patients: Observations on medication transfer during a safety and pharmacokinetic study
    Reed K., Knight A., Baillie S., Bogdanowicz K., Bell J., and Strang J.
  • The SCL90-Based psychopathological structure may be applied in substance use disorder patients independently of the drug involved, even in heroin, alcohol and cocaine monodrug users
    Carbone M.G., Maiello M., Spera V., Manni C., Pallucchini A., Maremmani A.G.I., and Maremmani I.
  • Comparing neurocognitive function in individuals receiving chronic methadone or buprenorphine for the treatment of opioid dependence: A systematic review.
    Hill D., Garner D., and Baldacchino A.
  • Medicinal products detected as novel psychoactive substances: The case of intravenous use of tropicamide.
    van Hout M.C.

 

Cover

Vol. 20 • No. NS2 • October 2018

In this issue:

Abstract book - 2nd World Congress of World Association on Dual Disorder - WADD - Florence, Italy, October 25-27, 2018

 

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465
Tel/Phone: 0584 - 790073 - Fax: 0584-72081 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page